News from the frontier of international medical materials: Molybdenum-rhenium alloy, as a new orthopaedic implant material, is considered to be the most developed due to its good biocompatibility, high strength, and excellent imaging performance under imaging diagnosis. Potential next-generation biomedical materials. Rhenium has carried out nearly eight years of cooperation in the research and development of orthopaedic implant materials with large European and American medical device manufacturers. At present, it can produce and deliver various specifications of molybdenum-rhenium alloy intermediate materials for orthopaedic implants with excellent performance, such as rods, plates, and pipes. and foils, as well as complete sets of human skeletal implants jointly developed by partners. At present, the molybdenum-rhenium implant jointly developed by our company and foreign partners has successfully passed the US FDA certification, and is seeking cooperation in the application and promotion of the Chinese medical market.